Humana Inc. (HUM)
| Market Cap | 35.39B |
| Revenue (ttm) | 115.01B |
| Net Income (ttm) | 1.36B |
| Shares Out | 120.41M |
| EPS (ttm) | 11.19 |
| PE Ratio | 26.25 |
| Forward PE | 18.33 |
| Dividend | $3.54 (1.21%) |
| Ex-Dividend Date | Dec 31, 2024 |
| Volume | 425,500 |
| Open | 290.97 |
| Previous Close | 293.13 |
| Day's Range | 286.82 - 294.91 |
| 52-Week Range | 213.31 - 502.73 |
| Beta | 0.53 |
| Analysts | Hold |
| Price Target | 306.48 (+4.29%) |
| Earnings Date | Jan 23, 2025 |
About HUM
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provid... [Read more]
Financial Performance
In 2023, Humana's revenue was $106.37 billion, an increase of 14.54% compared to the previous year's $92.87 billion. Earnings were $2.49 billion, a decrease of -11.30%.
Financial StatementsAnalyst Forecast
According to 24 analysts, the average rating for HUM stock is "Hold." The 12-month stock price forecast is $306.48, which is an increase of 4.29% from the latest price.
News
Humana says Susan Diamond to step down as CFO
Humana Inc said on Tuesday that Chief Financial Officer Susan Diamond was stepping down and Celeste Mellet would replace her, effective Jan. 11.
Humana Announces CFO Transition
LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that Celeste Mellet will be appointed to succeed Susan Diamond as Chief Financial Office...
Humana Appoints Michelle O'Hara as Chief Human Resources Officer
LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it has named Michelle O'Hara as Chief Human Resources Officer, effective January 1,...
Humana Recognized for Commitment to Veteran Employment by Military Times and Military Friendly®
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Recognized for Commitment to Veteran Employment by Military Times and Military Friendly®.
Humana Stock Slumps as Cigna Says It's Not Pursuing Combination
Humana (HUM) shares are falling 5% in premarket trading Monday after The Cigna Group (CI) said it is not pursuing a combination with its smaller health insurance rival.
Humana Stock Tumbles. Cigna Won't Pursue the Health Insurer.
Investors have long appeared skeptical about a potential merger between the two health insurers.
Cigna says it will not pursue combination with Humana
Health insurer Cigna Group said on Monday it is not pursuing a combination with peer Humana.
Trump Win Gives Some U.S. Health Insurers A Post-Election Bump On Wall Street
Several US health insurers saw notable stock price gains following the reelection of former US President Donald Trump amid an expectation of less federal scrutiny. Humana Inc. experienced the largest ...
Humana and Evolent Expand Partnership to Enhance Oncology Care
WASHINGTON--(BUSINESS WIRE)--Humana and Evolent expand their partnership to enhance oncology care and help drive better patient outcomes.
Why most healthcare stocks are falling with Trump's win, with some exceptions
Investors are worried about what a Trump administration means for hospital operators and vaccine makers, but are optimistic about the fate of Medicare Advantage plan providers.
Humana - Q3 Earnings Review: The Medicare Advantage Madness May Finally Be Over
Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA-focused companies. Despite headwinds, Humana's Q3 earnings showed resilien...
Humana Inc. Is Being Investigated For Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / November 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Humana Inc. ("...
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Humana Inc For Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / November 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Humana Inc. ("...
Humana Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Humana Inc. ("...
Humana Inc. (HUM) Q3 2024 Earnings Call Transcript
Humana Inc. (NYSE:HUM) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President and CEO Susan Diamond - CFO George Renaudin - P...
Humana's earnings boosted as Medicare Advantage membership exceeds expectations
The health insurer still sees full-year adjusted per-share earnings of at least $16.
Humana beats quarterly profit estimates
Humana beat Wall Street estimates for third-quarter profit on Wednesday, helped by strength in its government-backed Medicare Advantage insurance business for older adults.
Humana Reports Third Quarter 2024 Financial Results; Updates Full Year Adjusted 2024 Financial Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2024 (3Q24) versus the qua...
Humana's Payouts Will Get a Hard Look. Why the Election Matters More Than Earnings.
The health insurer's third-quarter report comes Wednesday. The numbers will show the growing problems with Medicare Advantage.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / October 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). ...
Humana Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Encouraged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / October 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Humana Inc. ("...
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESSWIRE / October 28, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). ...
Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) Shareholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESSWIRE / October 27, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Humana Inc. ("Humana" or "the Company") (NYSE:HUM). ...
The Schall Law Firm Urges Shareholders To Join An Inquiry Into Humana Inc For Securities Law Violations
LOS ANGELES, CA / ACCESSWIRE / October 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Humana Inc. ("...